Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • GenomeGuru
    Junior Member
    • Nov 2009
    • 1

    Position for a Bioinformatician in Cancer Epigenomics Research at IGBMC

    A position is open in the Gronemeyer laboratory at IGBMC for a bioinformatician to study the epigenomics of breast cancer and reference cancer models. The successful candidate will be involved in the analysis and integration of genome-wide biological data, develop bioinformatics tools and establish data analysis pipelines for High-Throughput Sequencing data (ChIP Seq & RNA Seq). The project will be done in collaboration with a major genome center in the world.

    Candidates must be highly motivated to work on biological questions and flexible to interact with the various members of the laboratory. They should have a degree in computational biology, bioinformatics, statistics or equivalent level of knowledge. Candidates must be comfortable working in UNIX/Linux environments and possess excellent programming skills (R, perl, python, etc). Experience in cloud computing would be considered an advantage. Operating language in the Institute is English. Applications including a cover letter, curriculum vitae and the names of two referees should be sent to: Dr. Irene Yujnovsky at [email protected]

    Information about the institute and the laboratory can be found at: http://www.igbmc.fr/recherche/Prog_F...ron/index.html
    Attached Files

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:26 AM
0 responses
10 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...